Department of Microbiology, University of
Texas Health Science Center at San Antonio, San Antonio, Texas
78284-7758
 |
INTRODUCTION |
Early in the process of endospore
formation, Bacillus subtilis partitions itself into two
unequal compartments with dissimilar developmental fates. The smaller
compartment ultimately becomes the spore, while the larger compartment
assumes the role of mother cell, engulfing and nurturing the developing
forespore and then lysing when the spore matures. Developmental gene
expression is unique to each of the two compartments and is dictated by
novel sigma (
) factors which become active only in one or the other compartment (reviewed in reference 39).
E is the first of the alternative sigma factors to
appear in the mother cell, with
F as its counterpart in
the forespore (9, 13, 16, 27, 28, 40). Both
E
and
F are synthesized at the onset of sporulation, but
neither is active until 1.5 to 2 h later, when the forespore
septum establishes the separate mother cell and forespore (9, 13,
21, 22, 27, 28, 41, 44, 45). Each of these sigma factors is kept
silent by unique means.
F is bound to an
anti-
F protein (SpoIIAB) which blocks its activity,
while
E is formed as a pro-protein
(pro-
E) which becomes active only after 27 amino acids
are cleaved from its amino terminus (1, 7, 8, 11, 12, 19, 22, 25,
30, 31, 36-38).
F is freed from SpoIIAB by the action of a second
protein (SpoIIAA), which triggers
F release by binding
to SpoIIAB (1, 8, 11). SpoIIAB is a SpoIIAA-specific kinase,
as well as a binding protein (1, 30). Phosphorylated SpoIIAA
is ineffective in driving the release of
F (10,
11). Before compartmentalization, most of the SpoIIAA is
phosphorylated and inactive. SpoIIAA-P is reactivated by a phosphatase
(SpoIIE) that becomes bound to the sporulation septum (2-4,
10). It has been speculated that the septal location of the
phosphatase might establish a higher phosphatase-to-kinase ratio in the
small forespore compartment than in the large mother cell and that
this could drive selective
F activation in the forespore
(10).
Activation of pro-
E requires a sporulation-specific
protease (SpoIIGA) that is coexpressed with pro-
E at the
onset of sporulation (18, 33, 38). Although both the
protease and substrate are present in the predivisional cell, the
processing reaction does not occur until a specific signal protein
(SpoIIR) triggers the reaction (20, 26). SpoIIR is produced
in the forespore under the control of
F (20,
26). It is believed that SpoIIGA is an integral membrane protein
that accumulates at the forespore septum membrane. At this site,
SpoIIGA is positioned to interact with SpoIIR, which is being secreted
by the forespore (15, 19). Thus, the activation of
E, as well as
F, is tied to the formation
of the forespore septum. This dependence on septation explains the
timing of
F and
E activation but leaves
the question of compartment-specific
E activation
unresolved. Both pro-
E and SpoIIGA, having been
synthesized before the sporulation cell division, should be present
in both compartments. An intriguing hypothesis is that there is
a directionality to SpoIIGA activation by SpoIIR and that only the
mother cell's SpoIIGA is positioned in the septal membrane in an
orientation appropriate to receive the SpoIIR signal
(15). Although this mechanism is possible, other factors are
likely to also be involved. Vegetative B. subtilis, expressing spoIIR from a gratuitous promoter, can process
pro-
E if SpoIIGA is present (26). Thus,
although transseptal signaling likely occurs, it does not appear to be
essential for processing. In addition, a strain of B. subtilis in which spoIIR was expressed prior to
septation still acquired mother cell-specific
E activity
(48). Apparently, a device other than the forespore-specific expression of spoIIR plays a role in establishing the mother
cell-specific activity of
E. Using a chimera of a
portion of pro-
E fused to green fluorescent protein
(GFP) as a probe of the processing reaction, we had found that
pro-
E::GFP could be processed following
septation if it was synthesized in the predivisional cell but not if it
was expressed from a forespore-specific promoter (e.g.,
PdacF) (19). This suggested that the
pro-
E processing reaction is limited to the mother cell,
although the reason for this restriction remained obscure. Recently,
Pogliano et al. used fluorescence microscopy to show that
pro-
E and
E are absent from the forespore
and that their disappearance requires functional SpoIIIE
(35). SpoIIIE is known to be essential for the translocation
of the distal 70% of the bacterial chromosome into the forespore
(46). In the present study, we examined this phenomenon in
greater detail and revisited the question of the mother cell-specific
processing of pro-
E. We found that the ability of SigE
to accumulate, when expressed from a forespore-specific promoter,
is dependent on the site of sigE expression on the
B. subtilis chromosome and the state of SpoIIIE.
PdacF-sigE is more likely
to generate a product which can accumulate and be processed into
E if it is expressed from a locus on the chromosome that
is translocated to the forespore early (e.g., amyE or
ctc) than if it lies at a late entering site (e.g.,
dacF). The absence of SpoIIIE further enhances this
accumulation and processing. We also determined that a
pro-
E::GFP hybrid protein, which had been
previously shown to be unprocessed if expressed in the forespore, is
processed in that compartment if it is either coexpressed with its
processing enzyme (SpoIIGA) or synthesized in a strain which lacks
SpoIIIE. Our data are consistent with the notion that a
forespore-specific factor, likely a proteolytic activity encoded by a
segment of the Bacillus chromosome which enters the
forespore late, blocks the formation of active
E in the
forespore by removing both pro-
E/
E and
SpoIIGA from that compartment.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
The B. subtilis strains and plasmids used in this study are listed in
Table 1. The transcriptional fusions of
the spoIIIG and dacF promoters to sigE
or sigE335 were constructed in two stages. A 0.43-kbp
HindIII/PstI fragment from pGSIIG11
(41), containing the spoIIIG promoter, or a
0.42-bp HindIII fragment from pPP212 (37),
containing the dacF promoter, were cloned into pUS19
(5) that had been cut with either HindIII or
HindIII/PstI, as appropriate. The promoters
were oriented toward the unique PstI site in the vector. A
PstI fragment of approximately 1.1 kbp, containing
sigE or sigE335 (32), was cloned into
this PstI site, downstream of each of the two promoters. The
resulting clones were analyzed by restriction endonuclease digestions
to verify proper orientation of sigE relative to the
promoters. This procedure yields plasmids pFE335, pGE335, pFE-1, and
pGE1 (Table 1). A DNA fragment containing spoIIGA, with
SalI and EcoRI sites bracketing it, was generated
by PCR techniques and cloned in the SalI/EcoRI site downstream site of the dacF promoter. This yielded
plasmid pFIIGA.
pEL-1 encodes a composite protein with the first 55 amino acids of
pro-
E fused to LacZ (17). Transcriptional
fusions of the spoIIIG and dacF promoters to
sigE-lacZ were constructed by joining the HindIII or HindIII-PstI
promoter pieces that were used in constructing the fusions of these
promoters to sigE to HindIII or
HindIII-PstI-cut pEL-1. This procedure yields
plasmid pGEL-1 (PspoIIIG) and pFEL-1 (PdacF).
PUK19 was constructed by cloning a 1.5-kbp ClaI fragment
carrying a gene encoding kanamycin resistance (aph3'5") from
pJH1 (23) into ClaI-cut pUC19. pUK191 is a
0.9-kbp EcoRI fragment from pCT050 (42)
containing the ctc gene cloned into the EcoRI site of pUK19. pF1 contains a
sigE55-gfp in-frame fusion under the
control of the dacF promoter. An inducible source of
F (Pspac-spoIIAC)
was introduced into strains by transformation with chromosomal DNA from
SL4342 (37) and selection for the linked Erm marker. Strains
containing dacF promoter fusions at amyE or
ctc were constructed by transforming the fusion plasmids into strains (SC191 and SL4834) with related plasmids already integrated at these sites. Clones in which the dacF fusions
had integrated at the amyE or ctc locus were
identified by cotransformation of the antibiotic resistances of the
dacF and resident plasmids.
Visualization of fluorescence.
Fluorescence was visualized
as described previously (4, 19, 24, 43). Culture samples of
200 µl were transferred to 1.5-ml microcentrifuge tubes on ice, 50 µl of preservation buffer (40 mM NaN3, 50% sucrose, 0.5 M Tris [pH 7.45], 0.77 M NaCl) was added, and the suspension was
incubated at 4°C for at least 2 h. A 3-µl aliquot of the cell
suspension was mixed with 1 µl of 4',6-diamidino-2-phenylindole
(DAPI, 1 µg/ml; Sigma) on a slide precoated with 0.01% polylysine
(Sigma) and covered with a polylysine-coated coverslip. Cells were
viewed with a Zeiss Axiophot epifluorescence microscope with a 100-W
mercury lamp source and a 100× Plan-Neofluar oil immersion objective
lens. Images were recorded on Kodak TMZ p3200 professional film. The
images were scanned and prepared with Adobe Photoshop version 4.0.
Images of the same field were obtained under conditions for recording
fluorescence of GFP, phase-contrast micrographs, and DAPI staining. The
camera was set at the automatic mode for all pictures. GFP fluorescence
was viewed with a fluorescein isothiocyanate filter set (Chroma
Technology; 450-490 exciter filter, FT510 chromatic beam splitter, and
LP520 barrier filter). DAPI-stained images were obtained with a
fluorescein isothiocyanate filter set (Chroma Technology; BP 365/12
exciter filter, FT395 chromatic beam splitter, and LP397 barrier
filter).
Western blot analysis.
Crude cell extracts were prepared
from B. subtilis by disrupting bacteria with a French
pressure cell. The protein concentration was determined by a Bio-Rad
protein assay in accordance with the manufacturer's instructions.
Extracts were fractionated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis with 12% acrylamide. Subsequent steps were as
described previously (41), using either locally prepared
anti-
E monoclonal antibody or commercial anti-GFP
monoclonal antibody (Clontech Laboratories, Inc., Palo Alto, Calif.) as
the probe. The commercial antibody cross-reacted with several proteins
in the crude extracts. These were variable with each antibody lot and
were identified by comparing the experimental extracts with similar
extracts from cells without the fusion. Bound antibody was visualized
with an alkaline phosphatase-conjugated goat immunoglobulin against
mouse immunoglobulin (American Qualex) by using either an alkaline
phosphate substrate kit (Bio-Rad) or CDP-Star (Boehringer Mannheim) as
the substrate reagent.
-Galactosidase assays.
Cells were harvested by
centrifugation, resuspended in Z buffer (29), and disrupted
by passage through a French pressure cell. Cell debris was removed by
centrifugation (10,000 × g) for 10 min, and the
supernatant was analyzed for
-galactosidase by using the reagents
described by Miller (29). Protein concentrations were
determined by a Bio-Rad assay using the procedures recommended by the
manufacturer.
-Galactosidase activity was expressed as
A420 × 1,000 × min
1 × mg of protein
1.
General methods.
DNA manipulation and the transformation of
Escherichia coli were done in accordance with standard
protocols. Transformation of competent B. subtilis
cells was carried out by the method of Yasbin et al. (47).
 |
RESULTS |
Expression of sigE335 from forespore-specific
promoters.
The product of the sigE335 allele lacks 15 amino acids in the pro-
E amino terminus (32).
It is not recognized for processing into mature
E, but
it is at least partially active without processing (32). The
smaller size of
E335 and its failure to be
converted into
E allow it to be distinguished from the
wild-type sigE products in Western blot analyses. To
investigate whether there are factors in the forespore that influence
E accumulation or activity in this compartment, we
joined sigE335 to promoters
(PdacF and PspoIIIG)
whose transcription depends on the forespore-specific
factor
F (37, 40). When
PdacF-sigE335 or
PspoIIIG-sigE335 is transferred on integrative plasmids into Bacillus, it can recombine into
the chromosomal sites of the promoter sequences (i.e., dacF
and spoIIIG). This results in a duplication of the
promoters, with one promoter driving sigE335 and the second
driving its normal operon. Integration is also possible at the
sigE sequences. At this site, most integration events would
exchange sigE335 for sigE as the allele that is
expressed from the normal sigE promoter
(PspoIIG) (41). Cells which carry
E335 as their principal source of
E are
Spo
(32). Approximately 20% of the
transformants that received either of the sigE335 plasmids
were Spo
. Western blot analysis of the sigE
proteins in extracts from representative Spo
clones
revealed only
E335, with its synthesis beginning when
PspoIIG becomes active at the onset of
sporulation (data not shown). These Spo
clones likely
represent transformants in which the plasmid integrated within
sigE to place sigE335 downstream of
PspoIIG. When the Spo+ transformants
were analyzed for their sigE products, pro-
E
and
E were readily observed, but no
E335
could be detected in the strains transformed with either
PdacF-sigE335 (Fig.
1A) or
PspoIIIG-sigE335 (Fig. 1C). To
verify that the putative PdacF-sigE335- and
PspoIIIG-sigE335-containing
strains were properly configured to express sigE335 in
response to
F activation, we transformed an inducible
source of
F (i.e.,
Pspac-spoIIAC) into these strains
and examined the effects of
F synthesis on
E335 accumulation during vegetative growth. As
shown in Fig. 1B and D, both the
PdacF-sigE335- and
PspoIIIG-sigE335-containing
strains accumulated
E335 in response to
F
induction.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
Accumulation of E335 and SigE55-LacZ in
B. subtilis strains. (A1 and
C1) Western blot analysis of B. subtilis
SFE1 (PdacF-sigE335) and SGE1
(PspoIIIG-sigE335), respectively.
Cells were grown in DS medium with samples taken at 1 (lanes 2), 3 (lanes 3), 5 (lanes 4), and 7 (lanes 5) h after the onset of
sporulation. Lanes 1 and 6 contain control extracts from wild-type
B. subtilis (SMY) and strain SE335 at
t3 of sporulation, respectively. Each lane
contained 100 µg of extract which was analyzed for SigE-like proteins
by Western blotting as described in Materials and Methods. The
positions at pro- E, E335, and
E are indicated. (A2 and C2)
-Galactosidase levels in B. subtilis SFE3
(PdacF-sigE55-lacZ)
and SGE3
(PspoIIIG-sigE55-lacZ).
Cells were grown in DS medium, and samples were taken at the indicated
times after the onset of sporulation and analyzed for -galactosidase
activity as described in Materials and Methods. -Galactosidase units
are expressed as A420 × 1,000 × min 1 × mg of protein 1. (B1 and
D1) Western blot analysis of strain SFE2
(PdacF-sigE335
PSPAC-spoIIAC) and SGE2
(PspoIIIG-sigE335
PSPAC-spoIIAC), respectively. Cells
were grown in LB medium and exposed to
isopropyl- -D-thiogalactopyranoside (IPTG; 1 mM) to
induce F synthesis. Samples were taken at the time of
IPTG addition (lanes 2) and 0.5 (lanes 3), 1 (lanes 4), and 1.5 (lanes
5) h thereafter and analyzed by Western blotting. Lanes 1 contain
strain SMY at t3. The positions of
pro- E, E335, and E are
indicated. (B2 and D2) -Galactosidase levels
in strain SFE4
(PdacF-sigE55-lacZ
PSPAC-spoIIAC) and SGE4
(PspoIIIG-sigE55-lacZ
PSPAC-spoIIAC), respectively. Cells,
grown in LB medium, were exposed to 1 mM IPTG ( ) or were allowed to
continue to grow in its absence ( ). Samples were taken at the time
of IPTG addition and at 0.5-h intervals thereafter and were analyzed
for -galactosidase activity as described above.
|
|
Our ability to detect
E335 from
PdacF-sigE335 and
PspoIIIG-sig335 following
F synthesis in vegetatively growing B. subtilis, but not during sporulation, suggests either that we are
inducing
F-dependent transcription more effectively in
our artificial system or that there are additional factors in the
sporulating cells that inhibit
E335 accumulation. To
test the relative activities of the dacF and spoIIIG promoters under our two conditions, we replaced the
sigE335 alleles in our constructions with a chimeric
sigE55-lacZ gene. The resulting
PdacF-sigE55-lacZ
and
PspoIIIG-sigE55-lacZ
genes have the
F-dependent promoters of the previous
constructions along with the sigE translational regulatory
elements and approximately 50 codons from the amino terminus of
sigE but express a
-galactosidase-like protein as their
product. When these constructions were transformed into B. subtilis, the resulting clones displayed appreciable
sporulation-specific
-galactosidase synthesis (Fig. 1A2
and C2). We then transformed PSPAC-spoIIAC into these strains
and examined the levels of
-galactosidase following
F
synthesis during vegetative growth. A comparison of the
-galactosidase levels formed under this circumstance with
that observed in sporulating cultures should reflect the relative
activities of the dacF and spoIIIG promoters
under these two conditions. We found that the
-galactosidase levels
of the vegetatively induced cultures were less than half of those seen
when the parent strains were allowed to sporulate (compare Fig.
1B2 and D2 with Fig. 1A2 and
C2). Thus, based on the relative levels of
-galactosidase that are seen under the artificial and natural
inducing conditions, we would have expected to see twice as much
E335 in the
PdacF-sigE335 and
PspoIIIG-sigE335 strains during
sporulation as was present following the vegetative inductions. The
absence of
E335 in the sporulating cultures argues that
there are additional factors that restrict
E335
accumulation within the forespore compartment at the time when the
dacF promoter becomes active. Given that
sigE-lacZ and sigE335 have
common transcriptional and translational regulatory elements, selective turnover of
E335 in the forespore becomes a
plausible possibility for its failure to accumulate.
Expression of sigE alleles from the amyE
locus in wild-type and spoIIIE mutant strains.
It has
been reported that pro-
E/
E can persist in
the forespore compartment of cells with mutations at spoIIIE
(35). SpoIIIE is an essential sporulation protein that is
needed for the translocation of the forespore's chromosome into that
compartment (46). In the absence of SpoIIIE, only the first
20 to 30% of the chromosome enters the forespore (46). For
a
F-dependent gene to be effectively expressed in a
spoIIIE mutant, it must be at a site on the chromosome that
enters the forespore. We wished to investigate the effects of the loss
of SpoIIIE on our ability to synthesize
E335 in the
forespore; however, neither the dacF nor spoIIIG
locus enters the forespore in a spoIIIE mutant strain.
We therefore transferred the
PdacF-sigE335 fusion to a site
(amyE) that does enter the forespore in a spoIIIE
mutant background. The strain we used in our analysis had an additional
mutation (sigE
84) which eliminates the synthesis of
pro-
E/
E from its normal locus
(spoIIG) (17, 32). In this strain, the product of
the
amyE::PdacF-sigE
fusion is the cell's sole source of SigE and the only protein that
will react with our anti-
E antibody in Western
blots. Prior to investigating the effect of a loss of
spoIIIE on
E335 accumulation, we examined the
expression of sigE335 at amyE in a strain
with a wild-type spoIIIE allele. Surprisingly,
sigE335 expressed from PdacF at the
amyE locus, unlike sigE335 expressed from this
same promoter at dacF, could be detected in Western blots
(Fig. 2A, lane 1). Although
E335 was evident, an abundant higher-mobility band was
also detected by the anti-
E antibody. We interpret this
secondary material to be a
E335 breakdown product. Our
ability to now detect
E335 from a forespore-expressed
promoter is not due to the absence of wild-type
sigE in this strain but rather to the expression of
sigE335 from the amyE locus. A strain with
PdacF-sigE335 at dacF
and the sigE
84 allele at spoIIG still fails to
accumulate
E335 (Fig. 2A, lane 3). Apparently,
E335 can accumulate to detectable levels in the
forespore if it is expressed from a site on the B. subtilis chromosome that translocates to the forespore early
(i.e., amyE) but not if it is expressed from a late entering
site (i.e., dacF or spoIIIG). We next examined the accumulation of
E335 in strains with null mutations
in spoIIIE. sigE335 expressed from
PdacF at amyE in a spoIIIE
mutant strain generated
E335; however, unlike the
SpoIIIE+ strain, the putative breakdown product was minimal
(Fig. 2A, lane 2). The presence of likely
E335 breakdown
products in the wild-type but not the spoIIIE mutant strain
suggests that
E335 is more stable in the absence of
SpoIIIE. This would be consistent with the finding of Pogliano et al.
that SpoIIIE facilitates the disappearance of
pro-
E/
E from the forespore
(35). Although the dacF locus does not
translocate to the forespore in the absence of SpoIIIE, the
PdacF-sigE335 fusion,
positioned at dacF in the sigE
84 spoIIIE
mutant strain, expressed a small amount of
E335
(Fig. 2A, lane 4). Presumably, the small amount of
E335
found in this strain is a consequence of
F activation in
the mother cell compartment.
F has been reported to
become partially active in the mother cell compartment in a SpoIIIE
mutant background (35, 44) and possibly more active if
E is also absent (35).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 2.
Western blot analysis of
PdacF-sigE335 (A) and
PdacF-sigE (B) in sporulating
B. subtilis. Cells were grown in DS medium and
harvested at 4 h after the onset of sporulation. Development of
the blots was normalized to a control sample included in the analysis.
One hundred micrograms of extract was analyzed for each lane except for
lane 5 in panel A, which contains 15 µg of protein from strain SMY at
t3. The positions of pro- E,
E335, and E are indicated. (A) Lanes: 1, SFE10 (sigE 84
amyE::PdacF-sigE335); 2, SFE11 (sigE 84 spoIIIE::spc
amyE::PdacF-sigE335); 3, SFE12 (sigE 84 PdacF-sigE335);
4, SFE13 (sigE 84 spoIIIE::spc
PdacF-sigE335); 5, SMY (wild type). (B)
Lanes: 1, SFE14 (sigE 84
amyE::PdacF-sigE); 2, SFE15 (sigE 84 spoIIIE::spc
amy::PdacF-sigE); 3, SFE16 (sigE 84 PdacF-sigE); 4, SFE17 (sigE 84 spoIIIE::spc
PdacF-sigE).
|
|
pro-
E is more stable than the products of
sigE alleles with deletions in their pro sequences (6,
22, 32). Assuming that pro-
E might be more
readily detectable than
E335 in the forespore
environment, where heightened proteolysis is suspected, we constructed
a PdacF-sigE fusion, placed it at
dacF or amyE, and examined the resulting strains
for evidence of pro-
E accumulation and processing.
PdacF-sigE expressed in a
sigE
84 background from either the amyE or
dacF locus yielded detectable products in Western blot
analyses (Fig. 2B). This accumulation was, however, approximately 10%
of that which we would have anticipated, based on the strength of the
dacF promoter (data not shown). The pro-
E
expressed at amyE (Fig. 2B, lane 1) was more abundant than
the pro-
E expressed at dacF (Fig. 2B, lane
3), and a portion of it was processed into mature
E.
Although there was no apparent processing of the pro-
E
that was expressed at the dacF locus (Fig. 2B, lane 3), the
degree of processing observed in the strain that expressed
pro-
E from amyE was minimal (Fig. 2B, lane 1)
and the synthesis of pro-
E from the dacF
locus was relatively low (Fig. 2B, lane 3). Thus, it is not clear if
the absence of processing in the latter case is due merely to low
pro-
E abundance and our failure to detect the processed
product or to the lack of a processing potential. The difference in the
relative abundance of the wild-type sigE products
synthesized at amyE versus those synthesized at
dacF was less than that which we observed for
sigE335 products. This may be due to the stabilizing effect of the pro sequence on the fusion that was expressed at
dacF. Disruption of spoIIIE resulted in an
increase in the ratio of mature
E to
pro-
E in the strain where pro-
E was
expressed at amyE (Fig. 2B, lane 2) and a detectable level of
E in the strain where sigE was expressed
at dacF (Fig. 2B, lane 4). As in the experiment described
above, we interpret the sigE products found in the
spoIIIE sigE
84
dacF-PdacF-sigE strain
as likely to be expressed by the mother cell due to a partial
activation of
F in that compartment.
Taken together, the data suggest that forespore-expressed
sigE products are more likely to accumulate and
produce detectable
E if they are either encoded at a
site that enters the forespore early or synthesized in a strain that
lacks a functional spoIIIE.
Effect of spoIIGA and sigE coexpression and
spoIIIE on pro-
E::GFP processing in the
forespore.
We had recently noted that a
pro-
E::GFP chimera can be processed into
E::GFP if it is expressed in the predivisional cell
but not if it is synthesized from PdacF in the
forespore (19). Pro-
E processing in
vegetative B. subtilis requires only SpoIIGA and SpoIIR
(26). It was therefore surprising that processing did not
occur in the forespore, where both of these proteins should also be
present. Given that SigE processing in the forespore, like its
accumulation, is more likely to occur if the pro-
E is
synthesized early, it seemed possible that SpoIIGA, like SigE, was
disappearing from the forespore. We therefore constructed a
B. subtilis strain in which both SpoIIGA and
pro-
E::GFP would be expressed from
PdacF. A B. subtilis strain
containing PdacF-sigE55-gfp
alone and one that also included
PdacF-spoIIGA were allowed to
sporulate. Samples were taken for Western blot analysis to monitor
potential pro-
E::GFP processing by using an anti-GFP
antibody (Clontech) as a probe. The commercial anti-GFP antibody
cross-reacted with several Bacillus proteins; however,
we were able to identify proteins corresponding to unprocessed
and processed pro-
E::GFP as bands of the predicted
mobilities, whose appearance depended on the presence of the
sigE-gfp fusion, progression of the culture to the appropriate time in sporulation, and the activity of the gene
products needed for pro-
E processing (e.g.,
spoIIGA). These bands are indicated in Fig. 3. As we had previously observed, the
strain carrying
PdacF-sigE55-gfp accumulated pro-
E::GFP at the time in sporulation
when
F would be expected to become active in the
forespore (t2) but failed to process it (Fig.
3A, lanes 1 to 4). The strain which expressed both spoIIGA
and sigE55-gfp from
PdacF not only formed pro-
E::GFP but displayed fusion protein processing
(Fig. 3A, lanes 5 to 8). Cells expressing the fusion proteins were
viewed by phase-contrast microscopy to visualize their outlines (Fig.
4A1 to F1) and by fluorescence microscopy to
localize both the GFP fusion proteins (Fig.
4A3
to F3) and DAPI-stained chromosomes (Fig. 4A2
to F2). As we had observed in the past (19), the
DAPI stain preferentially highlighted the mother cell chromosome,
presumably due to the difficulty of DAPI entry into the forespore
compartments (Fig. 4A2 and B2). The chimeric
GFP molecules of both
PdacF-sigE55-gfp strains were restricted to the forespore compartments (Fig.
4A3 and B3; Table
2). Thus, the
pro-
E::GFP processing that we observed in the
presence of coexpressed SpoIIGA is occurring in the forespore.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 3.
Western blot analysis of pro- E55::GFP
accumulation in sporulating B. subtilis. Total protein
(100 µg) from sporulating cells was fractionated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (12% acrylamide),
transferred to nitrocellulose, and probed with an anti-GFP monoclonal
antibody (Clontech). Cross-reacting proteins in the extracts were
identified by using B. subtilis extracts without the
fusion protein constructs as controls. Bound antibody was detected, by
using a secondary antibody conjugated to alkaline phosphatase (American
Qualex) and a chemoluminescent substrate (CDP-Star; Boehringer
Mannheim). The position of the unprocessed (Pro-GFP) and processed
(GFP) fusion proteins are indicated. (A) Lanes: 1 to 4, SFG1
(PdacF-sigE55-gfp);
5 to 8, SFG2
(PdacF-sigE55-gfp
PdacF-spoIIGA). (B) Lanes: 1 to 4, SFG4
(ctc::PdacF-sigE5-gfp);
5 to 8, SFG5
(ctc::PdacF-sigE55-gfp
PdacF-spoIIGA). (C) Lanes: 1 to 4, SFG3
(PdacF-sigE55-gfp
sigE 84 spoIIIE::spc); 5 to 8, SFG6
(ctc::PdacF-sigE55-gfp
sigE 84 spoIIIE::spc). Cells were harvested at
t1 (lanes 1 and 5), t2
(lanes 2 and 6), t3 (lanes 3 and 7), and
t4 (lanes 4 and 8).
|
|

View larger version (77K):
[in this window]
[in a new window]

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 4.
Localization of pro- E55::GFP in
sporulating B. subtilis. Stationary-phase B. subtilis cells were diluted 1/200 in DS medium and incubated for
12 h at 30°C. Sporulation-proficient cells had reached stage III
to IV by this time and the stage II mutants (SFG3 and SFG6) displayed a
disporic morphology. Samples were treated as described in Materials and
Methods to maximize GFP fluorescence and were then stained with DAPI.
Phase-contrast microscopy was used to visualize the cells
(A1 to F1). Fluorescent microscopy was used to
detect DAPI-stained chromosomal DNA (A2 to F2)
and GFP (A3 to F3). The arrows indicate the
positions of the same forespore compartments in each micrograph of the
series. (A) SFG1
(PdacF-sigE55-gfp);
(B) SFG2
(PdacF-sigE55-gfp,
PdacF-spoIIGA); (C) SFG3
(PdacF-sigE55-gfp
sigE84 spoIIIE::spc); (D) SFG4
(ctc::PdacF-sigE55-gfp);
(E) SFG5
(ctc::PdacF-sigE55-gfp
PdacF-spoIIGA); (F) SFG6
(ctc::PdacF-sigE55-gfp
sig 84 spoIIIE::spc).
|
|
We next examined whether the enhanced conversion of
pro-
E to
E that occurs in the
spoIIIE mutant could be replicated in the pro-
E::GFP system. If it could, the location of the
GFP fusion protein, and hence the site of processing, could be verified
by fluorescence microscopy. As in the previous experiments, in
which we tested the effects of the loss of SpoIIIE on SigE
accumulation, we first positioned the fusions at a site on the
chromosome (in this case, ctc) which would be transferred to
the forespore in the absence of SpoIIIE and verified their synthesis in
a SpoIIIE+ strain. Pro-
E::GFP
accumulated normally when expressed at this site (Fig. 3B) and was
localized to the forespore compartment (Fig. 4D; Table 2). The
pro-
E::GFP did not show evidence of obvious
processing in the absence of an additional source of SpoIIGA (Fig. 3B,
lanes 1 to 4) but was processed if a
PdacF-spoIIGA fusion was included
at ctc (Fig. 3B, lanes 5 to 8). Expression of
PdacF-sigE55-gfp
from sites at either dacF or ctc was then tested
in a SpoIIIE
background. The SpoIIIE
strain
used in this experiment is congenic with the strain used in the
sigE fusion experiment, i.e., it carries the
sigE
84 mutation at spoIIG. As a
consequence of this, it has a stage II, as well as a
SpoIIIE
, terminal phenotype. The stage II phenotype
associated with the sigE
84 mutation results in the
placement of a second septum at the pole of the cell opposite to that
at which the first septum is laid down. This is visible in the
DAPI-stained micrographs of this strain (Fig. 4C2 and
F2), where portions of each of the two chromosomes of the
sporulating cell are partitioned into each of these two polar
compartments. If
PdacF-sigE-gfp is
positioned at ctc in the spoIIIE::spc
sigE
84 strain, the GFP is localized to the two polar
compartments (Fig. 4F3; Table 2). Western blot analysis of
these cells reveals that virtually all of the
pro-
E55::GFP has been converted to the processed
form (Fig. 3C, lanes 5 to 8). We interpret these GFP results as
evidence that pro-
E processing can occur in the
forespore if either additional SpoIIGA is provided or the cell is
SpoIIIE
. Very little pro-
E::GFP was
synthesized in the SpoIIIE
strain from the
PdacF fusion at dacF, where
expression likely depends on
F activation in the mother
cell. The Western blot analysis of this strain failed to convincingly
detect a pro-
E::GFP band (Fig. 3C, lanes 1 to 4),
and fluorescence microscopy revealed weak whole-cell GFP fluorescence
(Fig. 4C3; Table 2).
 |
DISCUSSION |
Both pro-
E and its processing enzyme (SpoIIGA) are
synthesized in the predivisional cell; however, activation of
E in wild-type B. subtilis is ultimately
restricted to the mother cell compartment (27, 39). An
immunofluorescence study by Pogliano et al. (35) gave
compelling evidence for the absence of
pro-
E/
E from the forespore shortly after
septation (35). They also showed that in the absence of
SpoIIIE, a protein required for chromosome translocation to the
forespore, pro-
E/
E persisted and
E activity could be detected in the forespore.
While attempting to express sigE gene products from
forespore-specific promoters, we obtained data that support their
findings. A variant sigE allele (sigE335), whose
product can be distinguished electrophoretically from
pro-
E/
E, failed to accumulate in
wild-type B. subtilis (Fig. 1A and C) when it was
expressed from the forespore-specific dacF promoter. A
similar fusion that expressed the wild-type sigE allele did generate a product; however, its abundance was approximately 10% of
the level anticipated from the activity of the promoter that drove its
expression. Little wild-type SigE and no
E335 were found
to accumulate when expressed from the dacF locus, even
if the strain is unable to express mother cell-specific genes (i.e., it carries sigE
84 at spoIIG).
Thus, the factors restricting SigE's ability to persist in the
forespore do not require ongoing development in the mother cell and
instead appear to be independently developed by the forespore itself.
It is believed that the B. subtilis chromosome is
sequentially translocated into the forespore from a particular origin
(14, 46). The position of a gene on the chromosome
determines not only its time of transfer but also, as a consequence of
transfer time, the likely time at which the gene is expressed in the
forespore. Experimental evidence for this notion has recently been
obtained in the Piggot laboratory (34). These investigators
placed the
F-dependent spoIIR gene at
different sites on the B. subtilis chromosome and
demonstrated a correlation between its relative time of entry into the
forespore and the time at which its activity could be detected. In our
experiments,
E335 became visible in Western blots when
the PdacF::sigE335 fusion was
moved from late-entry sites (dacF and spoIIIG) to
an early-entry locus (amyE) (Fig. 2A, lane 1). We speculate
that this heightened SigE accumulation is due to its earlier synthesis.
This implies that the factor responsible for SigE's disappearance is
itself not present initially but accumulates in the forespore at this time. Presumably, this factor is a forespore-specific protease which
needs to be expressed from the translocated chromosome.
The result that pro-
E, synthesized in the forespore, was
more likely to be processed if it was expressed from a site that translocates to the forespore early or if the strain lacked SpoIIIE suggests that the capacity to process pro-
E, like the
ability to accumulate sigE products, is being lost in the
forespore due to expression of a gene on a distal part of the
translocated chromosome. A similar activity could be responsible for both events, with the SigE-processing enzyme (SpoIIGA), like SigE,
becoming unstable in the forespore. In support of this idea, we
found that supplemental SpoIIGA allows processing to occur in the
forespore (Fig. 3A, lanes 5 to 8). Processing also occurred in the
absence of additional SpoIIGA if the cell lacked SpoIIIE (Fig. 3C,
lanes 5 to 8). These results are consistent with SpoIIGA, as well as
SigE, being degraded by an activity that depends on SpoIIIE, presumably
a factor encoded on a distal region of the chromosome.
Our current view of pro-
E processing is illustrated in
Fig. 5. We had previously shown that the
SigE pro sequence tethers proteins which carry it to the forespore
septum (19). SpoIIGA, the pro-
E-processing
enzyme, has the structure of an integral membrane protein
(38), and, as proposed by Hofmeister et al. (15), may also reside in the forespore membrane. Hence,
pro-
E and SpoIIGA could both lie at the forespore
septum awaiting the signal to initiate the processing and release of
active
E into the cell interior. We suspect that
F-dependent genes are key for both the timing and the
compartmentalization of
E activity. Following septation
and
F activation, spoIIR, a gene that is on a
region of the chromosome that is translocated to the forespore early,
is transcribed and triggers pro-
E processing on both
sides of the forespore septum. As additional regions of the
B. subtilis chromosome enter the forespore, a
gene(s) encoding a putative protease(s) (X), which is hypothesized to degrade both SigE and SpoIIGA, enters the forespore and is expressed. This results in the elimination of these proteins from the forespore and a block of their further accumulation when their coding sequence (spoIIG), on a late-entering segment of the chromosome, is
finally transferred to the forespore. This model is highly speculative; however, if our notion of selective proteolysis is true, genetic screens should be able to detect the genes for these hypothetical proteases as the sites of mutations which allow SigE to persist and be
active in the forespore.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
Model for pro- E activation. SpoIIGA and
pro- E are synthesized prior to septation and are likely
to be present initially in both mother cell and forespore compartments.
As proposed by several investigators (15, 20, 26),
F becomes active in the forespore, where it directs the
synthesis of the SpoIIGA activator, SpoIIR. SpoIIR then signals SpoIIGA
to cleave the pro sequence from pro- E, which along with
SpoIIGA appears to be tethered to the septal membrane (15, 19, 20,
26). Very early after septation, this reaction probably occurs in
both the mother cell and forespore compartments; however, later, a
hypothetical F-dependent gene product (X)
initiates the destruction of both SigE and SpoIIGA in the forespore.
F-transcribed genes are proposed in this model to
be responsible for both the timing of E
activation, by directing the synthesis of SpoIIR, and the restriction
of E activity to the mother cell, by directing the
synthesis of the putative protease that degrades SpoIIGA and SigE.
|
|
This work was supported by NSF grant MCB-9417735.
| 1.
|
Alper, S.,
L. Duncan, and R. Losick.
1994.
An adenosine nucleotide switch controlling the activity of a cell type-specific transcription factor in B. subtilis.
Cell
77:195-205[Medline].
|
| 2.
|
Arigoni, F.,
L. Duncan,
S. Alper,
R. Losick, and P. Stragier.
1996.
SpoIIE governs the phosphorylation state of a protein regulating transcription factor F during sporulation in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
93:3238-3242[Abstract/Free Full Text].
|
| 3.
|
Arigoni, F.,
K. Pogliano,
C. Webb,
P. Stragier, and R. Losick.
1995.
Localization of protein implicated in establishment of cell type to sites of asymmetric cell division.
Science
270:637-640[Abstract/Free Full Text].
|
| 4.
|
Barák, I.,
J. Behari,
G. Olmedo,
P. Guzman,
D. P. Brown,
E. Castro,
D. Walker,
J. Westpheling, and P. Youngman.
1996.
Structure and function of the Bacillus SpoIIE protein and its localization to sites of sporulation septum assembly.
Mol. Microbiol.
19:1047-1060[Medline].
|
| 5.
|
Benson, A. K., and W. G. Haldenwang.
1993.
Regulation of B levels and activity in Bacillus subtilis.
J. Bacteriol.
175:2347-2356[Abstract/Free Full Text].
|
| 6.
|
Carlson, H. C.
1994.
.
Ph.D. thesis.
University of Texas Health Science Center, San Antonio.
|
| 7.
|
Carlson, H. C.,
S. Lu,
L. Kroos, and W. G. Haldenwang.
1996.
Exchange of precursor-specific elements between pro- E and pro- K of Bacillus subtilis.
J. Bacteriol.
178:546-549[Abstract/Free Full Text].
|
| 8.
|
Diederich, B.,
J. F. Wilkinson,
T. Magnin,
S. M. A. Najafi,
J. Errington, and M. D. Yudkin.
1994.
Role of interactions between SpoIIAA and SpoIIAB in regulating cell-specific transcription factor F of Bacillus subtilis.
Genes Dev.
8:2653-2663[Abstract/Free Full Text].
|
| 9.
|
Driks, A., and R. Losick.
1991.
Compartmentalized expression of a gene under the control of sporulation transcription factor E in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
88:9934-9938[Abstract/Free Full Text].
|
| 10.
|
Duncan, L.,
S. Alper,
F. Arigoni,
R. Losick, and P. Stragier.
1995.
Activation by cell-specific transcription by a serine phosphatase at the site of asymmetric division.
Science
270:641-644[Abstract/Free Full Text].
|
| 11.
|
Duncan, L.,
S. Alper, and R. Losick.
1996.
SpoIIAA governs the release of the cell-type specific transcription factor F from its anti-sigma factor SpoIIAB.
J. Mol. Biol.
260:147-164[Medline].
|
| 12.
|
Duncan, L., and R. Losick.
1993.
SpoIIAB is an anti- factor that binds to and inhibits transcription by regulatory protein F from Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
90:2325-2329[Abstract/Free Full Text].
|
| 13.
|
Errington, J., and N. Illing.
1992.
Establishment of cell specific transcription during sporulation in Bacillus subtilis.
Mol. Microbiol.
6:689-695[Medline].
|
| 14.
|
Feucht, A.,
T. Magnin,
M. D. Yudkin, and J. Errington.
1996.
Bifunctional protein required for asymmetric cell division and cell-specific transcription in B. subtilis.
Genes Dev.
10:794-803[Abstract/Free Full Text].
|
| 15.
|
Hofmeister, A. E. M.,
A. Londoño-Vallejo,
E. Harry,
P. Stragier, and R. Losick.
1995.
Extracellular signal protein triggering the proteolytic activation by a developmental transcription factor in B. subtilis.
Cell
83:219-226[Medline].
|
| 16.
|
Illing, N., and J. Errington.
1991.
Genetic regulation of morphogenesis in Bacillus subtilis: roles of E and F in prespore engulfment.
J. Bacteriol.
173:3159-3169[Abstract/Free Full Text].
|
| 17.
|
Jonas, R. M.,
H. K. Peters III, and W. G. Haldenwang.
1990.
Phenotypes of Bacillus subtilis mutants altered in the precursor-specific region of E.
J. Bacteriol.
172:4178-4186[Abstract/Free Full Text].
|
| 18.
|
Jonas, R. M.,
E. A. Weaver,
T. J. Kenney,
C. P. Moran, Jr., and W. G. Haldenwang.
1988.
The Bacillus subtilis spoIIG operon encodes both E and a gene necessary for E activation.
J. Bacteriol.
170:507-511[Abstract/Free Full Text].
|
| 19.
|
Ju, J.,
T. Luo, and W. Haldenwang.
1997.
Bacillus subtilis pro- E fusion protein localizes to the forespore septum and fails to be processed when synthesized in the forespore.
J. Bacteriol.
179:4888-4893[Abstract/Free Full Text].
|
| 20.
|
Karow, L. M.,
P. Glaser, and P. J. Piggot.
1995.
Identification of a gene, spoIIR, which links the activation of E to the transcriptional activity of F during sporulation in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
92:2012-2016[Abstract/Free Full Text].
|
| 21.
|
Kenney, T. J., and C. Moran, Jr.
1987.
Organization and regulation of an operon that encodes a sporulation-essential sigma factor in Bacillus subtilis.
J. Bacteriol.
169:3329-3339[Abstract/Free Full Text].
|
| 22.
|
LaBell, T.,
J. E. Trempy, and W. G. Haldenwang.
1987.
Sporulation specific factor, 29 of Bacillus subtilis, is synthesized from a precursor protein, p31.
Proc. Natl. Acad. Sci. USA
84:1784-1788[Abstract/Free Full Text].
|
| 23.
|
Le Blanc, D. J.,
J. M. Inamine, and L. N. Lee.
1986.
Broad geographical distribution of homologous erythromycin, kanamycin and streptomycin resistance determinants among group D streptococci of human and animal origin.
Antimicrob. Agents Chemother.
29:549-555[Abstract/Free Full Text].
|
| 24.
|
Lewis, P. J., and J. Errington.
1996.
Use of green fluorescent protein for detection of cell-specific gene expression and subcellular protein localization during sporulation in Bacillus subtilis.
Microbiology
142:733-740[Abstract].
|
| 25.
|
Lewis, P. J.,
T. Magnin, and J. Errington.
1996.
Compartmentalized distribution of the proteins controlling the prespore-specific transcription factor F of Bacillus subtilis.
Genes Cells
1:881-894.
[Abstract] |
| 26.
|
Londoño-Vallejo, J.-A., and P. Stragier.
1995.
Cell-cell signaling pathway activating a developmental transcription factor in Bacillus subtilis.
Genes Dev.
9:503-508[Abstract/Free Full Text].
|
| 27.
|
Losick, R., and P. Stragier.
1992.
Crisscross regulation of cell-type specific gene expression during development in B. subtilis.
Nature (London)
355:601-604[Medline].
|
| 28.
|
Margolis, P.,
A. Driks, and R. Losick.
1991.
Establishment of cell type by compartmentalized activation of a transcription factor.
Science
254:562-565[Abstract/Free Full Text].
|
| 29.
|
Miller, J. H.
1972.
.
Experiments in molecular genetics.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 30.
|
Min, K.-T.,
C. M. Hilditch,
B. Diederich,
J. Errington, and M. D. Yudkin.
1993.
F, the first compartmental-specific factor of B. subtilis, is regulated by an anti- factor that is also a protein kinase.
Cell
74:735-742[Medline].
|
| 31.
|
Miyao, A.,
G. Theragool,
M. Takeuchi, and Y. Kobayashi.
1993.
Bacillus subtilis spoVE gene is transcribed by E-associated RNA polymerase.
J. Bacteriol.
175:4081-4086[Abstract/Free Full Text].
|
| 32.
|
Peters, H. K., III,
H. C. Carlson, and W. G. Haldenwang.
1992.
Mutational analysis of the precursor-specific region of Bacillus subtilis E.
J. Bacteriol.
174:4629-4637[Abstract/Free Full Text].
|
| 33.
|
Peters, H. K., III, and W. G. Haldenwang.
1994.
Isolation of a Bacillus subtilis spoIIGA allele that suppresses processing-negative mutations in the pro- E gene (sigE).
J. Bacteriol.
176:7763-7766[Abstract/Free Full Text].
|
| 34.
| Piggot, P. Personal communication.
|
| 35.
|
Pogliano, K.,
A. E. M. Hofmeister, and R. Losick.
1997.
Disappearance of the E transcription factor from the forespore and the SpoIIE phosphatase from the mother cell contributes to establishing cell-specific gene expression during sporulation in Bacillus subtilis.
J. Bacteriol.
179:3331-3341[Abstract/Free Full Text].
|
| 36.
|
Schmidt, R.,
P. Margolis,
L. Duncan,
R. Coppolecchia, and C. P. Moran, Jr.
1990.
Control of transcription factor F by sporulation regulatory proteins SpoIIAB in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
87:9221-9225[Abstract/Free Full Text].
|
| 37.
|
Schuch, R., and P. Piggot.
1994.
The dacF-spoIIA operon of Bacillus subtilis, encoding F, is autoregulated.
J. Bacteriol.
176:4104-4110[Abstract/Free Full Text].
|
| 38.
|
Stragier, P.,
C. Bonamy, and C. Karmazyn-Campelli.
1988.
Processing of a sporulation sigma factor in Bacillus subtilis: how morphological structure could control gene expression.
Cell
52:697-704[Medline].
|
| 39.
|
Stragier, P., and R. Losick.
1996.
Molecular genetics of sporulation in Bacillus subtilis.
Annu. Rev. Genet.
30:297-341[Medline].
|
| 40.
|
Sun, D.,
P. Stragier, and P. Setlow.
1989.
Identification of a new sigma factor involved in compartmentalized gene expression during sporulation of Bacillus subtilis.
Genes Dev.
3:141-149[Abstract/Free Full Text].
|
| 41.
|
Trempy, J. E.,
C. Bonamy,
J. Szulmajster, and W. G. Haldenwang.
1985.
Bacillus subtilis sigma factor sigma 29 is the product of the sporulation essential gene spoIIG.
Proc. Natl. Acad. Sci. USA
82:4189-4192[Abstract/Free Full Text].
|
| 42.
|
Truitt, C. L.,
G. L. Ray,
J. E. Trempy,
Z. Da-Jian, and W. G. Haldenwang.
1985.
Isolation of Bacillus subtilis mutants altered in expression of a gene transcribed in vitro by a minor form of RNA polymerase (E- 37).
J. Bacteriol.
161:515-522[Abstract/Free Full Text].
|
| 43.
|
Webb, C. D.,
A. Decatur,
A. Teleman, and R. Losick.
1995.
Use of green fluorescent protein for visualization of cell-specific gene expression during sporulation in Bacillus subtilis.
J. Bacteriol.
177:5906-5911[Abstract/Free Full Text].
|
| 44.
|
Wu, J. J.,
M. G. Howard, and P. J. Piggot.
1989.
Regulation of transcription of the Bacillus subtilis spoIIA locus.
J. Bacteriol.
171:692-698[Abstract/Free Full Text].
|
| 45.
|
Wu, J.-J.,
R. Schuch, and P. J. Piggot.
1992.
Characterization of a Bacillus subtilis sporulation operon that includes genes for an RNA polymerase factor and for a putative DD-carboxypeptidase.
J. Bacteriol.
174:4885-4892[Abstract/Free Full Text].
|
| 46.
|
Wu, L. J., and J. Errington.
1994.
Bacillus subtilis SpoIIIE protein required for DNA segregation during asymmetri |